Medical therapy of otitis media: Use, abuse, efficacy, and morbidity

Journal of Otolaryngology

Volumn 27, Issue SUPPL. 2, 1998, Pages 26-36

  Bitnun, Ari ^a   Allen, Upton D ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Antibiotics; Otitis media; Resistance; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFTIBUTEN; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; INFLUENZA VACCINE; MACROLIDE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; STEROID; TETRACYCLINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE EAR EFFUSION; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PRIORITY JOURNAL; RECURRENT INFECTION; STEROID THERAPY; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; HUMANS; INFANT; OTITIS MEDIA; RECURRENCE; STREPTOCOCCAL INFECTIONS;

EID: 0031768510     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Alho OP, Koivu M, Sorri M, Rantakallio P. The occurrence of otitis media in infants. A life-table analysis. Int J Pediatr Otorhinolaryngol 1991; 21:7-14.
2. Casselbrant ML, Mandel EM, Kurs-Lasky M, et al. Otitis media in a population of black American and white American infants, 0-2 years of age. Int J Pediatr Otorhinolaryngol 1995; 33:1-16.
3. Lundgren K, Ingvarsson L. Epidemiology of acute otitis media in children. Scand J Infect Dis 1983; 15(Suppl 39):19-25.
4. Sipila M, Pukander J, Karma P. Incidence of acute otitis media up to the age of 1 1/2 years in urban infants. Acta Otolaryngol (Stockh) 1987; 104:138-145.
5. Teele DW, Klein JO, Rosner B, and the Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: a prospective, cohort study. J Infect Dis 1989; 160:83-94.
6. Paradise JL, Rockette HE, Colhorn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics 1997; 99:318-333.
7. Pukander J, Luotonen J, Timonen M, Karma P. Risk factors affecting the occurrence of acute otitis media among 2-3-year-old urban children. Acta Otolaryngol (Stockh) 1995; 15:(Table 2C).
8. Kero P, Piekkala P. Factors affecting the occurrence of acute otitis media during the first year of life. Acta Paediatr Scand 1987; 76:618-623.
9. Etzel RA, Pattishall EN, Haley NJ, et al. Passive smoking and middle ear effusion among children in day care. Pediatrics 1992; 90:228-232.
10. Duncan B, Ey J, Holberg CJ, et al. Exclusive breast-feeding for at least 4 months protects against otitis media. Pediatrics 1993; 91:867-872.
11. Herman S, Roark R, Luckey D. Theoretical cost effectiveness of management options for children with persisting middle ear effusions. Pediatrics 1994; 93:353-363.
12. McCraig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United-States. JAMA 1995; 273:214-219.
13. Paradise JL. Treatment guidelines for otitis media: the need for breadth and flexibility. Pediatr Infect Dis J 1995; 14: 429-435.
14. Dowell SF, Marcy SM, Phillips WR, et al. Otitis media-principles of judicious use of antimicrobial agents. Pediatrics 1998; 101(suppl 1):165-171.
15. Barnett ED, Klein JO. The problem of resistant bacteria for the management of acute otitis media. Pediatr Clin North Am 1995; 42:509-517.
16. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992; 11: S7-S11.
17. Block SL. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J 1997; 16:449-456.
18. Doern GV and the Alexander Project Collaborative Group. Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae: results of a 1992-1993 Western Europe and USA collaborative surveillance study. J Antimicrob Chemother 1996; 38(suppl A):59-69.
19. Enright MC. McKenzie H. Moraxella (Branhamella) catarrhalis - clinical and molecular aspects of a rediscovered pathogen. J Med Microbiol 1997; 46:360-371.
20. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. In: Sixth informational supplement: NCCLS Document M100-S6. Villanova, PA: National Committee for Clinical Laboratory Standards, 1995:15 (14).
21. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3:171-196.
22. Schreiber JR, Jacobs MR. Antibiotic-resistant pneumococci. Pediatr Clin North Am 1995; 42:519-537.
23. Hansman D, Bullen MM. A resistant pneumococcus. Lancet 1967; 2:264-265.
24. Caputo GM, Appelbaum PC, Liu HH. Infections due to penicillin-resistant pneumococci. Arch Intern Med 1993; 153:1301-1310.
25. Appelbaum PC. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J 1996; 15:932-939.
26. Linares J, Pallares R, Alonso T, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992; 15:99-105.
27. Marton A. Pneumococcal antimicrobial resistance: the problem in Hungary. Clin Infect Dis 1992; 15:106-111.
28. Garcia-Leoni ME, Cercenado E, Rodeno P, et al. Susceptibility of Streptococcus pneumomae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis 1992; 14:427-435.
29. Doern GV, Brueggemann A, Holley HP Jr, Ranch AM. Antimicrobial resistance Streptococcus pneumomae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40:1208-1213.
30. Nava JM, Bella F, Garau J, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994; 19:884-890.
31. Lee H-J, Park J-Y, Jang S-H, et al. High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea. Clin Infect Dis 1995; 20:826-835.
32. Song JH and the Asian Network for Surveillance of Resistant Pneumococci Study Group. Prevalence of drug-resistant pneumococci in 11 Asian countries. In: Programs and Abstracts on 37th Interscience Conference on Antimicrobials Agents and Chemotherapy, Toronto, 1997. Abstract C-48.
33. Jacobs MR. Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media. Pediatr Infect Dis J 1996; 15:940-943.
34. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995; 14:751-759.
35. Del Castillo F, Baquero-Artigao F, Garcia-Perea A. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain. Pediatr Infect Dis J 1998; 17:94-97.
36. Rodriguez WJ, Schwartz RH, Thorne MM. Increasing incidence of penicillin- and ampicillin-resistant middle ear pathogens. Pediatr Infect Dis J 1995; 14:1075-1078.
37. Geslin P, Buu-Hoi A, Acar JF. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clin Infect Dis 1992; 15:95-98.
38. Dagan R, Yagupsky P, Goldbart A, et al. Increasing prevalence of penicillin-resistant pneumococcal infections in children in southern Israel: implications for future immunization policies. Pediatr Infect Dis J 1994; 13:782-786.
39. Gray BM, Converse GM III, Dillon HC. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage , and infection during the first 24 months of life. J Infect Dis 1980; 142:923-933.
40. Arnold KE, Leggiadro RJ, Breiman RF, et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr 1996; 128:757-764.
41. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multi-drug resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995; 14:745-750.
42. Boken DJ, Chartrand SA, Goering RV, et al. Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center. Pediatr Infect Dis J 1995; 14:879-884.
43. Zenni Mk, Cheatham SH, Thompson JA, et al. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr 1995; 127:533-537.
44. Brook I, Gober AE. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children. Clin Infect Dis 1996; 22:143-145.
45. Klugman KP, Koornhof HJ, Wasas A, et al. Carriage of penicillin resistant pneumococci. Arch Dis Child 1986; 61:377-381.
46. Appelbaum PC, Gladkova C, Hryniewicz W, et al. Carriage of antibiotic-resistant Streptococcus pneumoniae by children in eastern and central Europe - a multicenter study with use of standardized methods. Clin Infect Dis 1996; 23:712-717.
47. Dagan R, Melamed R, Muallem M, et al. Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines. J Infect Dis 1996; 174:1352-1355.
48. Bhavnani SM, Forrest A, Hyatt JM, et al. Factors associated with nasopharyngeal acquisition of penicillin-resistant S. pneumoniae during the first two years of life. In: Programs and Abstracts on 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, 1997. Abstract C-53.
49. Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992; 166:1346-1353.
50. Radetsky MS, Istre GR, Johansen TL, et al. Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care center. Lancet 1981; 2:771-773.
51. Appelbaum PC, Bhamjee A, Scragg JN, et al. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 1977; 2:995-997.
52. Butler JC, Hofmann J, Cetron MS, et al and the Pneumococcal Sentinel Surveillance Working Group. The continued emergence of drug-resistant Streptococcus pneumoniae in the United-States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996; 174:986-993.
53. Breiman RF, Butler JC, Tenover FC, et al. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271:1831-1835.
54. Stool SE, Berg AO, Berman S, et al. Otitis media with effusion in young children. Clinical practice guideline. Agency of Health Care Policy and Research Publication. No. 94-0622, 1994.
55. Hayden GF. Acute suppurative otitis media in children. Clin Pediatr 1981; 20:99-104.
56. Paradise JL, Smith CG, Bluestone CD. Tympanometric detection of middle ear effusion in infants and children. Pediatrics 1976; 58:198-210.
57. Kaleida PH, Stool SE. Assessment of otoscopist's accuracy regarding middle-ear effusion. Am J Dis Child 1992; 146: 433-435.
58. Bluestone CD, Cantekin EI. Design factors in the characterization and identification of otitis media and certain related conditions. Ann Otol Rhinol Laryngol 1979; 88(suppl 60): 13-28.
59. Finitzo T, Friel-Patti S, Chinn K, Brown O. Tympanometry and otoscopy prior to myringotomy: issues in diagnosis of otitis media. Int J Pediatr Otorhinolaryngol 1992; 24:101-110.
60. Toner JG, Mains B. Pneumatic otoscopy and tympanometry in the detection of middle ear effusion. Clin Otolaryngol 1990; 15:121-123.
61. Vaughan-Jones R, Mills RP. The Welch Allyn audioscope and microtymp: their accuracy and that of pneumatic otoscopy, tympanometry and pure tone audiometry as predictors of otitis media with effusion. J Laryngol Otol 1992; 106:600-602.
62. Hayden GF, Schwartz RH. Characteristics of earache among children with acute otitis media. Am J Dis Child 1985; 139:721-723.
63. Pukander J. Clinical features of acute otitis media among children. Acta Otolaryngol (Stockh) 1983; 95:117-122.
64. Schwartz RH, Stool SE, Rodriguez WJ, Grundfast KM. Acute otitis media. Clin Pediatr 1981; 20:549-554.
65. Arola M, Ruuskanen O, Ziegler T, et al. Clinical role of respiratory virus infection in acute otitis media. Pediatrics 1990; 86:848-855.
66. Browning GG. Childhood otalgia: acute otitis media. Br Med J 1990; 300:1005-1006.
67. Al-Sheikhli ARJ. Pain in the ear - with special reference to referred pain. J Laryngol Otol 1980; 94:1433-1440.
68. Ingvarsson L. Acute otalgia in children-findings and diagnosis. Acta Paediatr Scand 1982; 71:705-710.
69. Baker RB. Is ear pulling associated with ear infection? Pediatrics 1992; 90:1006-1007.
70. Schwartz RH, Rodriguez WJ, Brook I, Grundfast KM. The febrile response in acute otitis media. JAMA 1981; 245: 2057-2058.
71. Niemela M, Uhari M, Jounio-Ervasti K, et al. Lack of specific symptomatology in children with acute otitis media. Pediatr Infect Dis J 1994; 13:765-768.
72. Rudberg RD. Acute otitis media: comparative therapeutic results of sulfonamide and penicillin administered in various forms. Acta Otolaryngol Suppl (Stockh) 1954; 113:1-79.
73. Van Buchem FL, Peeters MF, Van'T Hof MA. Acute otitis media: a new treatment strategy. Br Med J 1985; 290: 1033-1037.
74. Diamant M, Diamant B. Abuse and timing of use of antibiotics in acute otitis media. Arch Otolaryngol 1974; 100: 226-232.
75. Paradise JL. Managing otitis media: a time for change. Pediatrics 1995; 96:712-715.
76. Van Buchem FL, Dunk JH, Van'T Hof MA. Therapy of acute otitis media: myringotomy, antibiotics or neither? Lancet 1981; 2:883-887.
77. Mygind N, Meistrup-Larsen KI, Thomsen J, et al. Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clin Otolaryngol 1981; 6:5-13.
78. Kaleida PH, Casselbrant ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics 1991; 87:466-474.
79. Rosenfeld RM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media - metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr 1994; 124:355-366.
80. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J 1993; 12:973-975.
81. Howie VM, Ploussard JH, Lester RL. Otitis media: a clinical and bacteriologic correlation. Pediatrics 1970; 45:29-35.
82. Axelsson I. Overtreatment of otitis media. Pediatr Infect Dis J 1993; 12:889-890.
83. Fry J. Antibiotics in acute tonsillitis and acute otitis media. Br Med J 1958; 2:883-886.
84. Froom J, Culpepper L, Jacobs M, et al. Antimicribials for acute otitis media? A review from the international primary care network. Br Med J 1997; 315:98-102.
85. Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. Br Med J 1997; 314:1526-1529.
86. Pichichero ME, Pichichero CL. Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J 1995; 14:178-183.
87. Pichichero ME, Pichichero CL. Persistent acute otitis media: II. Antimicrobial treatment. Pediatr Infect Dis J 1995; 14: 183-188.
88. Marchant CD, Carlin SA, Johnson CE, Shunn PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon." J Pediatr 1992; 120:72-77.
89. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996; 15:944-948.
90. McCracken GH. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr Infect Dis J 1995; 14:424-428.
91. Mason WH. The management of common infections in ambulatory children. Pediatr Ann 1996; 25:620-630.
92. Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J 1997; 16:680-695.
93. Barnett ED, Teele DW, Klein JO, et al., and the Greater Boston Otitis Media Study Group. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Pediatrics 1997; 99:23-28.
94. Gudnason T, Gudbrandson F, Barsanti F, Kristinsson K. Penetration of ceftriaxone into the middle ear fluid of children. Pediatr Infect Dis J 1998; 17:258-260.
95. Teele DW, Klein JO, Rosner BA. Epidemiology of otitis media in children. Ann Otol Rhinol Laryngol 1980; 89(suppl 68):5-6.
96. Marchant CD, Shurin PA, Turczyk VA, et al. Course and outcome of otitis media in early infancy. J Pediatr 1984; 104:826-831.
97. Zielhuis GA, Straatman H, Rach GH, Van der Broek P. Analysis and presentation of data on the natural course of otitis media with effusion in children. Int J Epidemiol 1990; 19:1037-1044.
98. Teele DW, Klein JO, Chase C, et al., and the Greater Boston Otitis Media Study Group. Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. J Infect Dis 1990; 162:685-694.
99. Williams RL, Chalmers TC, Stange KC, et al. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion. JAMA 1993; 270:1344-1351.
100. Rosenfeld RM, Post JC. Meta-analysis of antibiotics for the treatment of otitis media with effusion. Otolaryngol Head Neck Surg 1992; 106:378-386.
101. Rosenfeld RM, Mandel EM, Blucstone CD. Systemic steroids for otitis media with effusion in children. Arch Otolaryngol Head Neck Surg 1991; 117:984-989.
102. Paap CM. Management of otitis media with effusion in young children. Ann Pharmacother 1996; 30:1291-1297.
103. Cantekin EI, Mandel EM, Bluestone CD, et al. Lack of efficacy of decongestant-antihistamine combination for otitis media with effusion ("secretory" otitis media) in children. N Engl J Med 1983; 308:297-301.
104. Luotonen M, Uhjri M, Aitola L, et al. Recurrent otitis media during infancy and linguistic skills at the age of nine years. Pediatr Infect Dis J 1996; 15:854-858.
105. Wright PF, Sell SH, McConnell KB, et al. Impact of recurrent otitis media on middle ear function, hearing , and language. J Pediatr 1988; 113:581-587.
106. Biedel CW. Modification of recurrent otitis media by short-term sulfonamide therapy. Am J Dis Child 1978; 132:681-683.
107. Berman S, Nuss R, Roark R, et al. Effectiveness of continuous vs. intermittent amoxicillin to prevent episodes of otitis media. Pediatr Infect Dis J 1992; 11:63-67.
108. Gonzalez C, Arnold JR, Woody KA, et al. Prevention of recurrent acute otitis media: chemoprophylaxis versus tympanostomy rubes. Laryngoscope 1986; 96:1330-1334.
109. Casselbrant ML, Kaleida PH, Rockette HE, et al. Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: results of a randomized clinical trial. Pediatr Infect Dis J 1992; 11:278-286.
110. Paradise JL, Bluestone CD, Rogers KD, et al. Efficacy of adenoidectomy for recurrent otitis media in children previously treated with tympanostomy-tube placement. JAMA 1990; 263:2066-2073.
111. Heikkinen T, Ruuskanen O, Waris M, et al. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991; 145:445-448.
112. Makela PH, Leinonen M, Pukander J, Karma P. A study of the pneumococcal vaccine in the prevention of clinically acute attacks of recurrent otitis media. Rev Infect Dis 1981; 3(suppl):124-130.
113. Sloyer JL, Ploussard JH, Howie VM. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville. Alabama. Rev Infect Dis 1981; 3(suppl):119-113.
114. Schuller DE. Prophylaxis of otitis media in asthmatic children. Pediatr Infect Dis J 1983: 2:280-283.
115. Butler JC, Breiman RF, Lipman HR, et al. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis 1995; 171:885-889.
116. Anderson EL, Kennedy DJ, Geldmacher KM, et al. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 1996; 128:649-653.
117. Dagan R, Melamed R, Zamir O, Leroy O. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F, and 23F polysaccharides conjugated to either tetanus toxoid or diphteria toxoid in young infants and their boosterability by native polysaccharide antigens. Pediatr Infect Dis J 1997; 16:1053-1059.
118. Ahman H, Kayhty H, Lehtonen H, et al. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J 1998; 17: 211-216.
119. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate vaccine. J Infect Dis 1996; 174:1271-1278.
120. Dagan R, Muallem M, Melamed R, et al. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphteria toxoid. Pediatr Infect Dis J 1997; 16:1060-1064.